AU2012253414B2 - Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof - Google Patents

Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof Download PDF

Info

Publication number
AU2012253414B2
AU2012253414B2 AU2012253414A AU2012253414A AU2012253414B2 AU 2012253414 B2 AU2012253414 B2 AU 2012253414B2 AU 2012253414 A AU2012253414 A AU 2012253414A AU 2012253414 A AU2012253414 A AU 2012253414A AU 2012253414 B2 AU2012253414 B2 AU 2012253414B2
Authority
AU
Australia
Prior art keywords
cancer
methylation
nucleic acid
sample
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012253414A
Other languages
English (en)
Other versions
AU2012253414A1 (en
Inventor
Andrew P. Feinberg
Rafael I. Irizarry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2012253414A1 publication Critical patent/AU2012253414A1/en
Application granted granted Critical
Publication of AU2012253414B2 publication Critical patent/AU2012253414B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2012253414A 2011-05-12 2012-05-10 Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof Active AU2012253414B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161518892P 2011-05-12 2011-05-12
US61/518,892 2011-05-12
PCT/US2012/037362 WO2012154979A2 (en) 2011-05-12 2012-05-10 Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof

Publications (2)

Publication Number Publication Date
AU2012253414A1 AU2012253414A1 (en) 2013-11-21
AU2012253414B2 true AU2012253414B2 (en) 2016-03-17

Family

ID=47140012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012253414A Active AU2012253414B2 (en) 2011-05-12 2012-05-10 Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof

Country Status (5)

Country Link
US (2) US10752953B2 (enExample)
EP (1) EP2707506B1 (enExample)
JP (2) JP2014519319A (enExample)
AU (1) AU2012253414B2 (enExample)
WO (1) WO2012154979A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3004478A1 (en) * 2015-11-06 2017-05-11 University Of Southern California Development of prognostic markers dsg-3 from the saliva of oral cancer patients
WO2017218908A2 (en) * 2016-06-16 2017-12-21 The Johns Hopkins University Methods and system for epigenetic analysis
AU2017340743A1 (en) 2016-10-06 2019-04-18 Memorial Sloan Kettering Cancer Center Large-scale epigenomic reprogramming links anabolic glucose metabolism to distant metastasis during the evolution of pancreatic cancer progression
GB201703406D0 (en) * 2017-03-02 2017-04-19 Ucl Business Plc Diagnostic and prognostic methods
CN108796079B (zh) * 2018-06-06 2021-07-27 天津医科大学肿瘤医院 一种逆转录转座基因l1-fggy及其作为肺鳞癌标志物的用途
US12100517B2 (en) * 2018-10-29 2024-09-24 Flatiron Health, Inc. Generalized biomarker model
GB201819452D0 (en) * 2018-11-29 2019-01-16 Ucl Business Plc Differential methylation
US11001898B2 (en) 2019-05-31 2021-05-11 Universal Diagnostics, S.L. Detection of colorectal cancer
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
US12467096B2 (en) 2020-05-15 2025-11-11 Universal Diagnostics, S.A. Methods and systems for identifying methylation biomarkers
WO2022002424A1 (en) 2020-06-30 2022-01-06 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
CN116710574A (zh) * 2020-12-04 2023-09-05 赢创运营有限公司 用于对禽类肠道炎症状态进行分类的方法
JP7709178B2 (ja) * 2021-12-09 2025-07-16 国立大学法人北海道大学 リンパ腫に罹患したイヌの化学療法後の予後予測方法
JP2023174077A (ja) * 2022-05-27 2023-12-07 株式会社日立製作所 Ｄｎａのメチル化レベルの測定方法、疾患予測システム、及び検査システム

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050064401A1 (en) * 2000-09-01 2005-03-24 Alexander Olek Diagnosis of illnesses or predisposition to certain illnesses
WO2005059172A2 (en) * 2003-12-11 2005-06-30 Epigenomics Ag Method and nucleic acids for the improved treatment of breast cell proliferative disorders
WO2010062914A1 (en) * 2008-11-26 2010-06-03 The Johns Hopkins University Methods for identifying cancer risk

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
JP2004524030A (ja) * 2001-02-23 2004-08-12 ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン 膵臓がんにおけるメチル化の異なる配列
EP1442129B1 (en) 2001-10-18 2008-09-10 Lovelace Respiratory Research Institute Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes
WO2009021141A1 (en) 2007-08-07 2009-02-12 The Johns Hopkins University Comprehensive high throughput arrays for relative methylation
US8399193B2 (en) * 2007-08-30 2013-03-19 City Of Hope DNA methylation biomarkers for lung cancer
WO2009113771A1 (ko) * 2008-03-14 2009-09-17 (주)지노믹트리 폐암특이적 메틸화 마커 유전자를 이용한 폐암 검출방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050064401A1 (en) * 2000-09-01 2005-03-24 Alexander Olek Diagnosis of illnesses or predisposition to certain illnesses
WO2005059172A2 (en) * 2003-12-11 2005-06-30 Epigenomics Ag Method and nucleic acids for the improved treatment of breast cell proliferative disorders
WO2010062914A1 (en) * 2008-11-26 2010-06-03 The Johns Hopkins University Methods for identifying cancer risk

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARADEO, M.E. et al., FEBS Letts. 2011, vol. 585, pages 2112-2120 *

Also Published As

Publication number Publication date
US12454725B2 (en) 2025-10-28
WO2012154979A3 (en) 2013-03-28
AU2012253414A1 (en) 2013-11-21
JP2020010700A (ja) 2020-01-23
WO2012154979A2 (en) 2012-11-15
JP2014519319A (ja) 2014-08-14
EP2707506A4 (en) 2014-12-24
US10752953B2 (en) 2020-08-25
JP6954964B2 (ja) 2021-10-27
US20210071262A1 (en) 2021-03-11
US20140128283A1 (en) 2014-05-08
EP2707506B1 (en) 2018-07-11
EP2707506A2 (en) 2014-03-19

Similar Documents

Publication Publication Date Title
AU2012253414B2 (en) Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof
JP7168247B2 (ja) 癌スクリーニング及び胎児分析のための変異検出
AU2022218555B2 (en) Methylation pattern analysis of haplotypes in tissues in DNA mixture
US10196698B2 (en) DNA methylation markers for metastatic prostate cancer
CN112322736B (zh) 一种用于检测肝癌的试剂组合，试剂盒及其用途
Linton et al. Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours
US20160108476A1 (en) Colorectal cancer markers
WO2019195941A1 (en) Dna methylation assays and methods
CN112280865B (zh) 一种用于检测肝癌的试剂组合，试剂盒及其用途
CN112501293A (zh) 一种用于检测肝癌的试剂组合，试剂盒及其用途
Hua et al. DNA methylome profiling identifies novel methylated genes in epithelial ovarian cancer patients with platinum resistance
US20240352537A1 (en) Composition for diagnosing prostate cancer by using cpg methylation changes in specific genes, and use thereof
KR102901130B1 (ko) 대규모 코호트 유래 전장 유전체 연관 분석 및 dna 메틸화 분석을 이용한 간 섬유화 진단용 바이오마커 조성물
US20230102121A1 (en) Reagent combination and kit for detecting liver cancers, and use thereof
EP4628597A1 (en) Dna methylation markers for diagnosing esophageal cancer and stomach cancer and use thereof
HK40075962A (en) Methylation pattern analysis of haplotypes in tissues in dna mixture
KR20240087391A (ko) 복막 전이성 위암 진단용 바이오마커를 선별하는 방법 및 상기 방법에 의해 선별된 바이오마커
WO2025032045A1 (en) Multi-cancer detection assay
WO2024066941A1 (zh) 一种用于检测膀胱癌的组合物，试剂盒及其用途
KR20240087388A (ko) 난소 전이성 위암 진단용 바이오마커를 선별하는 방법 및 상기 방법에 의해 선별된 바이오마커
HK40031442A (en) Methylation pattern analysis of haplotypes in tissues in dna mixture
HK40031442B (en) Methylation pattern analysis of haplotypes in tissues in dna mixture
CN117660640A (zh) 辅助检测肺癌体细胞egfr基因突变的甲基化生物标记物、试剂盒及方法
HK1248283B (en) Methylation pattern analysis of haplotypes in tissues in dna mixture

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)